Cargando…

Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment

PURPOSE: We aimed to investigate the feasibility of four criteria on oligometastasis (OM) concerning clear survival benefits of local therapy (LT) during tyrosine kinase inhibitor (TKI) treatment in non–small cell lung cancer (NSCLC). MATERIALS AND METHODS: This single-center, retrospective study in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Yoon Jung, Hyun, Dong-gon, Ji, Wonjun, Choi, Chang-Min, Yoon, Shinkyo, Lee, Dae Ho, Kim, Sang-We, Lee, Jae Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101786/ https://www.ncbi.nlm.nih.gov/pubmed/36470259 http://dx.doi.org/10.4143/crt.2022.1342

Ejemplares similares

Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung
por: Jang, Yoon Jung, et al.
Publicado: (2021)

Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis
por: Hyun, Dong-gon, et al.
Publicado: (2020)

Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatment
por: Choi, Myeong Geun, et al.
Publicado: (2022)

Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
por: Poon, Ian, et al.
Publicado: (2020)

Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study
por: Choi, Myeong Geun, et al.
Publicado: (2021)

Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer
por: Ji, Wonjun, et al.
Publicado: (2013)

Diagnosis of oligometastasis
por: Terao, Mayako, et al.
Publicado: (2020)

microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015)

Stereotactic Radiotherapy for Oligometastasis
por: Otake, Sotaro, et al.
Publicado: (2019)

Oligometastasis: More Lessons to Be Learned
por: Kim, Kyung Hwan, et al.
Publicado: (2023)

Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
por: Mazzola, Rosario, et al.
Publicado: (2020)

Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer
por: Cho, Su Han, et al.
Publicado: (2021)

Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma
por: Kim, Jwa Hoon, et al.
Publicado: (2021)

Role of Local Treatment for Oligometastasis: A Comparability-Based Meta-Analysis
por: Rim, Chai Hong, et al.
Publicado: (2022)

Metastasis-directed therapy for oligometastasis and beyond
por: Beckham, Thomas H., et al.
Publicado: (2020)

Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor
por: Kwon, Byoung Soo, et al.
Publicado: (2020)

MicroRNA Expression Characterizes Oligometastasis(es)
por: Lussier, Yves A., et al.
Publicado: (2011)

Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching Analysis
por: Yoon, Byung Woo, et al.
Publicado: (2019)

Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations
por: Kim, Ho Cheol, et al.
Publicado: (2019)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
por: Malone, Julia, et al.
Publicado: (2020)

Oligometastasis: Expansion of Curative Treatments in the Field of Oncology
por: Lim, Ah Reum, et al.
Publicado: (2023)

Prognostic Utility of Histological Growth Patterns of Colorectal Lung Oligometastasis
por: Yeong, Son Jae, et al.
Publicado: (2018)

Oligometastasis and oligo-recurrence: more than a mirage
por: Huang, Fang, et al.
Publicado: (2014)

Barriers in Oligometastasis Care in Korea: Radiation Oncologists’ Perspectives
por: Chie, Eui Kyu, et al.
Publicado: (2023)

OLIGOMETASTASIS IN GASTRIC CANCER TREATMENT: IS THERE A PLACE FOR THE SURGEON?
por: de ASSUMPÇÃO, Paulo Pimentel, et al.
Publicado: (2023)

Successful treatment of induced oligometastasis and repeated oligoprogression of advanced lung adenocarcinoma with immunotherapy and radiotherapy
por: Lee, Ho Young, et al.
Publicado: (2022)

Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
por: Hiraki, Takao, et al.
Publicado: (2012)

Revisiting a Null Hypothesis: Exploring the Parameters of Oligometastasis Treatment
por: Scarborough, Jessica A., et al.
Publicado: (2021)

Photodynamic therapy for treatment of recurrent adenocarcinoma of the lung with tracheal oligometastasis
por: Singh, Harpreet, et al.
Publicado: (2022)

Metastasis-Directed Local Therapy of Hepatic Oligometastasis from Colorectal Cancer and Future Perspective in Radiation Therapy
por: Yoo, Gyu Sang, et al.
Publicado: (2023)

Long-term survival after multimodal treatment involving radiotherapy for huge hepatocellular carcinoma with oligometastasis: a case report
por: Lee, Byung Min, et al.
Publicado: (2021)

Nivolumab as maintenance therapy following platinum‐based chemotherapy in EGFR ‐mutant lung cancer patients after tyrosine kinase inhibitor failure: A single‐arm, open‐label, phase 2 trial
por: Kim, Jiwon, et al.
Publicado: (2023)

Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis
por: He, Jinyuan, et al.
Publicado: (2017)

Percutaneous Polidocanol Injection as an Alternative Treatment in Differentiated Thyroid Cancer Oligometastasis
por: Alvarez Castillo, Marlen Alejandra, et al.
Publicado: (2021)

Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma
por: Chang, Yoon Soo, et al.
Publicado: (2016)

WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
por: Haznedaroğlu, İbrahim C., et al.
Publicado: (2020)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
por: Masbuchin, Ainun Nizar, et al.
Publicado: (2022)

Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors
por: Won, Sang Eun, et al.
Publicado: (2020)

EUS-guided radiofrequency ablation for a left adrenal oligometastasis of an esophageal adenocarcinoma
por: Inderson, Akin, et al.
Publicado: (2018)

Small cell lung cancer with thyroid gland oligometastasis: A case report
por: Tsutsui, Toshiharu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sbqg9tm8jjdgkqjh9s03dmqpdj